Wogonin Inhibits IL-6-Induced Angiogenesis via Down-Regulation of VEGF and VEGFR-1, not VEGFR-2

Abstract

So far, no antiangiogenic activity of wogonin, a flavonoid, on human umbilical vein endothelial cells (HUVECs) has been demonstrated. The aim of this study was to investigate the effects of wogonin on IL-6-induced angiogenesis in HUVEC cultures and chorioallantoic membrane (CAM) neovascularization. The in vivo CAM model was applied to evaluate the percentage of new vessel formations, followed by measurement of endothelial migration and tube formation in HUVEC cultures. The results revealed that wogonin (10^-8∼10^-5M) concentration-dependently inhibited IL-6-induced angiogenesis. The signaling pathway was through down-regulation of the autocrine loop of VEGF and VEGFR-1, but not of VEGFR-2. Furthermore, the regulating loop of the IL-6 receptor complex was also attenuated via expression of sIL-6Rα and gp130, but not of IL-6/IL-6R binding density. We conclude that wogonin is a suppressive agent of the autoregulated loop of VEGF, VEGFR-1 and the IL-6 receptor complex.

Key words

Wogonin - angiogenesis - IL-6 - IL-6R - VEGF - VEGFR-1

References

• 1 Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M. et al . Cancer prevention by natural compounds.  . 2004;  19 245-63
• 2 Kanadaswami C, Lee L T, Lee P P, Hwang J J, Ke F C, Huang Y T. et al . The antitumor activities of flavonoids.  . 2005;  19 895-909
• 3 Lee , Kim Y O, Kim H, Kim S Y, Noh H S, Kang S S. et al . Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia.  FASEB J. 2003;  17 1943-4
• 4 Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi.  Biochem Biophys Acta. 1999;  1472 643-50
• 5 Chang Y L, Shen J J, Wung B S, Cheng J J, Wang D L. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells.  Mol Pharmacol. 2001;  60 507-13
• 6 Augustin H G. Antiangiogenic tumor therapies - will it work.  Trends Pharmacol Sci. 1998;  19 216-22
• 7 Feghali C A, Wright T M. Cytokines in acute and chronic inflammation.  Bioscience. 1997;  2 12-26
• 8 Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction modeling.  Circ Res. 2004;  94 1543-53
• 9 Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay J Y. Prognostic value of serum levels of interleukin 6 and serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.  Br J Cancer. 2003;  88 1721-6
• 10 Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation.  Clin Sci (Lond). 2005;  108 205-13
• 11 Aggarwal B B, Bhardwaj A, Aggarwal R S, Seeram N P, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.  Anticancer Res. 2004;  24 2783-840
• 12 Jaffe E A, Nachman R L, Becker C G, Minick C R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.  J Clin Invest. 1973;  52 2745-56
• 13 Hernandez-Rodriguez J, Sergarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban M J. et al . Elevated production of interleukin-6 as associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis.  Circulation. 2003;  107 2428-34
• 14 Lay I S, Chiu J H, Shiao M S, Lui W Y, Wu C W. Crude extract of Salvia mitiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line.  Planta Med. 2003;  69 26-32
• 15 Nicosia R F, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro .  Lab Invest. 1990;  63 15-22
• 16 Lin S K, Tsai S C, Lee C C, Wang B W, Liou J Y, Shyu K G. Berberine inhibits HIF-1 expression via enhanced proteolysis.  Mol Pharmacol. 2004;  66 612-9
• 17 Taga T, Kishimoto T. Cytokine receptors and signal transduction.  FASEB J. 1992;  6 3387-96
• 18 Yang S H, Lin J K, Huang C J, Chen W S, Li S Y, Chiu J H. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor upregulation.  J Surg Res. 2005;  128 140-6
• 19 Nakamura N, Hayasaka S, Zhang X Y, Nagaki Y, Matsumoto M, Hayasaka Y. et al . Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappa b binding activities induced by interleukin-1 beta in human retinal pigment epithelial cell line.  Exp Eye Res. 2003;  77 195-202
• 20 Park B K, Heo M Y, Park H, Kim H P. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix.  Eur J Pharmacol. 2001;  425 153-7
• 21 Ravindranath M H, Muthugounder S, Presser N, Viswannthan S. Anticancer therapeutic potential of soy isoflavone, genistein.  Adv Exp Med Biol. 2004;  546 121-65
• 22 Fang J, Xia C, Cao Z, Zheng J Z, Reed E, Jiang B H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.  FASEB J. 2005;  19 342-53
• 23 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease.  Nat Med. 1995;  1 27-31
• 24 Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.  Cardiovasc Res. 2001;  49 568-81
• 25 Jackson M W, Roberts J S, Heckford S E, Ricciardelli C, Stahl J, Horsfall D J. et al . A potential autocrine role for vascular endothelial growth factor in prostate cancer.  Cancer Res. 2002;  62 854-9
• 26 Fong G H, Rossant J, Gertsenstein M, Breitman M L. Role of the Flt-1 receptor tyrosine kinase in regulation the assembly of vascular endothelium.  Nature. 1995;  376 66-70
• 27 Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis.  Am J Physiol Cell Physiol. 2001;  280 C1358-66
• 28 Heinrich P C, Behrmann I, Haan S, Hermanns H M, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6- type cytokine signaling and its regulation.  Biochem J. 2003;  374 1-20
• 29 Marin V, Montero-Julian F A, Gres S, Boulay V, Bongrand P, Farnarier C. et al . The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.  J Immunol. 2001;  167 3435-42
• 30 Molostvov G, Morris A, Rose P, Basu S, Muller G. The effects of selective cytokines inhibiting drugs (CC-10 004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures.  Br J Haematol. 2004;  124 366-75